Evidence map›Paper›PMID 42029926›Full record

ArticlePediatric cardiology2026

Fetal cardiomyopathy secondary to infiltrative cardiac fibroma.

Myriam Almeida-Jones, Jay Pruetz, Jeffrey Goldstein, Susanna Tran, Ruchira Garg, Mark S Sklansky

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Myriam Almeida-JonesDepartments of Cardiology and Pediatrics, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA. Myriam.Almeida-Jones@csmc.edu.
Jay PruetzDepartments of Cardiology and Pediatrics, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.
Jeffrey GoldsteinDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Susanna TranDepartments of Cardiology and Pediatrics, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.
Ruchira GargDepartments of Cardiology and Pediatrics, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.
Mark S SklanskyDepartments of Cardiology and Pediatrics, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fetal dilated cardiomyopathy carries a variable but generally poor prognosis, depending largely upon the etiology. Many cases of fetal cardiomyopathy develop during the second or third trimester. Similarly, fetal cardiac tumors typically present during the second or third trimester, but tumors have not previously been found to cause dilated cardiomyopathy during fetal life. We report a case of an infiltrative fetal cardiac fibroma presenting as a form of right ventricular dilated cardiomyopathy during the second trimester. Fetal cardiomyopathy secondary to an infiltrative cardiac tumor should be considered in the differential of fetal dilated cardiomyopathy.

Indexed as

Cardiac fibromaCardiac tumorCongenital heart diseaseFetal dilated cardiomyopathyFetal echocardiography

Identifiers

PMID42029926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.